About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BostonGene Wins Four GlobalData’s Clinical Trials Arena Excellence Awards

Awards Recognize BostonGene’s Significant Strides to Advance Precision Diagnostics and Improve Patient Outcomes in Innovation, Product Launches and Business Expansion Categories

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced it has received four Clinical Trials Arena Excellence Awards in the categories of Business Expansion, Innovation and Product Launches. These awards underscore BostonGene’s commitment to advancing personalized therapies and improving outcomes for cancer patients and individuals with immune-related diseases.

The Clinical Trials Arena Excellence Awards is an independent recognition program by GlobalData, utilizing researchers, journalists, and artificial intelligence (AI) to analyze over 1 billion datasets yearly. It aims to acknowledge, endorse, and rank top-tier companies and their achievements in over 200 countries. Regarded as one of the industry's largest and most respected programs, it holds significant value and is the voice of authority.

"We extend our congratulations to BostonGene for winning four Clinical Trials Arena Excellence Awards and topping the chart in the Innovation category," stated Tina Ross, Awards Manager, Clinical Trials Arena Excellence Awards. "BostonGene is transforming precision medicine with their cutting-edge work in molecular diagnostics by improving outcomes for patients, equipping providers with invaluable insights and providing pharmaceutical companies with critical data to accelerate drug development."

"BostonGene is deeply honored to receive these awards from GlobalData," said Andrew Feinberg, President and CEO of BostonGene. "These awards not only showcase our accomplishments but also our momentum moving forward as we continue to capitalize on our AI-driven diagnostic technologies to facilitate drug development and treatment selection."

In the Innovation category, BostonGene was honored with two awards: one for its groundbreaking Kassandra™ machine learning algorithm for bulk RNA-seq cell type deconvolution and the second award for its proprietary AI-driven clinical trial-matching algorithm. BostonGene was also honored as the Overall Winner in the category.

BostonGene's Product Launches award celebrates the development of a new Liquid Biopsy assay. The CLIA-certified and CAP-accredited test detects clinically actionable gene alterations to predict treatment response and monitor disease progression.

The Business Expansion award recognizes BostonGene's launch of CLIA-certified and CAP-accredited Liquid Biopsy, Immunoprofiling, and Spatial Proteomics solutions, complementing the Tumor PortraitTM next-generation sequencing-based laboratory-developed test. These platforms offer a comprehensive view of each patient’s disease, supporting discovery, translational and clinical efforts in precision oncology.

About BostonGene Corporation

BostonGene has a mission to provide transformative, AI-integrated molecular analytics and biomarker discovery for precision matching of therapies to improve the lives of patients living with cancer and other immune-related diseases. BostonGene’s concierge-service model provides customized client solutions using a multi-omic approach prioritized for real-world impact to optimize standard-of-care therapies, accelerate research and provide cost-effective, measurable data-driven results. BostonGene’s tests reveal key drivers of each patient’s unique disease profile, including an in-depth profile of the immune microenvironment, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene’s tests generate a personalized roadmap for therapeutic decision-making for each patient. For more information, visit BostonGene at http://www.BostonGene.com.

BostonGene is transforming precision medicine with their in molecular diagnostics by improving outcomes for patients, equipping providers with invaluable insights and providing pharma companies with critical data to accelerate drug development...

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.